Director/PDMR Shareholding

RNS Number : 8487Q
Polypipe Group PLC
02 December 2016
 

 

Polypipe Group plc (the "Company")

Notification of transactions by Person Discharging Managerial Responsibilities

The Company announces that today, 2 December 2016, Martin Payne, a Person Discharging Managerial Responsibilities, exercised a nil-cost option over 50,601 ordinary shares of £0.001 each in the capital of the Company ('Shares'), in accordance with the Deferred Share Award that was granted to him on 31 May 2016, full details of which were included in a regulatory announcement released on 31 May 2016. The Company's Employee Benefit Trust has today transferred 26,819 Shares to Mr. Payne which represents the net number of Shares due to him after appropriate tax and national insurance liabilities were taken into account. Mr. Payne now holds an interest in a total of 56,819 Shares in the Company.

The notification below, which has been made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Martin Payne

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer/Director and PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Polypipe Group plc

b)

 

LEI

 

 

2138005IF1N2RKJ6KO18

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares ("Shares") of £0.001 each in the capital of Polypipe Group plc

 

 

GB00BKRC5K31

 

b)

 

Nature of the transaction

 

 

Acquisition of Shares for no consideration pursuant to the exercise of nil-cost options granted as a Deferred Share Award on 31 May 2016.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

 

50,601 - Number of Shares vesting and over which options were exercised.

 

26,819 -Shares acquired after reduction for appropriate tax and national insurance liabilities.

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

2 December 2016

f)

 

Place of the transaction

 

 

Outside of a Trading Venue

 

Enquiries:

David Hall, Chief Executive Officer

Martin Payne, Chief Financial Officer

+44 (0) 1709 772284

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHAKBDPBBDDNBK

Companies

Genuit Group (GEN)
UK 100